Phase II Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2018
At a glance
- Drugs Milciclib (Primary)
- Indications Malignant thymoma
- Focus Therapeutic Use
- Sponsors Nerviano Medical Sciences; Tiziana Life Sciences
- 17 Jul 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2017.
- 27 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jan 2017.
- 08 Nov 2016 Status changed from recruiting to active, no longer recruiting.